Sabinsa Corporation manufactures
and markets phytonutrients, Ayurvedic herbal extracts and specialty
fine chemicals for nutritional, pharmaceutical and food industries.
Sabinsa has carved a niche for itself by its extensive
research support for its customers and products, and the scientific
credentials of its key technical staff.
Founded in 1988, Sabinsa is a company dedicated to
the principles of tradition, innovation and research. Sabinsa's
efforts have begun to earn the company vast recognition, in addition
to growing sales.
In October 1995, Dr. Muhammed
Majeed, founder of Sabinsa, received the National Award for
Quality Products (Basic Drugs) from the President of India.
In 1996 and 1997, the company
has been placed in the top ten among New Jersey's top 50 fastest
growing technology-based companies (NJ Technology Fast 50 Awards).
In 1996 and 1997, Sabinsa
was amongst the top 100 companies in the prestigious INC. 500,
which is the magazine's annual list of the 500 fastest growing
private companies.
Today, Sabinsa manufactures
over 20 synthetic intermediates used in the pharmaceutical and nutritional
industries, 20 nutritional fine chemicals and over 50 standardized
herbal extracts and herb powders. A recently introduced cosmeceuticals
line includes 10 standardized natural extracts.
Latest
News
Breaking News
Sami Labs has Halal Certification in addition to Kosher Certificate Details
___________________________
Muhammed Majeed, Ph.D.
Sabinsa Corp
INSIDER Details
___________________________
Two formerly trusted and valued employees of Sabinsa/Sami Labs are pursuing our customers worldwide by portraying similar products as superior and/or less expensive and from their own production. Details
___________________________
Sabinsa/Sami Labs inks exclusive distribution agreement with Degussa Goldschmidt personal care Details
Latest Patents
Issued United States Patent on Cococin:
7,300,682 issued on November 27, 2007
Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance More
___________________________
United States Patent
7,253,324 issued on August 7, 2007
Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers More
Letter
from CEO of Sabinsa
An Open Letter to our friends in the Nutritional
Industry Details
Awards
Sabinsa Corporation Awarded for Selenomethionine and ForsLean Details
______________________________
